Veterans face disproportionately high rates of lung cancer, often diagnosed too late for the most effective treatments. In this episode, NAVREF CEO Rashi Romanoff and RWJBarnabas Health pulmonologist Dr. Michael Nicholson explore how CyPath Lung, a non-invasive, home-based sputum test powered by AI, can transform lung cancer screening and early detection for veterans.

In this episode, a multidisciplinary panel of pulmonology, thoracic surgery and oncology experts discusses real-world lung nodule cases and how noninvasive CyPath® Lung testing can help refine risk stratification. The panel explores when testing may support decisions to pursue biopsy, when a negative result may help avoid unnecessary invasive procedures, and how multidisciplinary collaboration can improve the management of patients with indeterminate lung nodules. The experts also look ahead to the evolving role of noninvasive testing in lung nodule management.

In this episode, a multidisciplinary panel - an interventional pulmonologist, thoracic surgeon, and medical oncologist - explores the growing challenge of indeterminate lung nodules in high-risk patients. The experts discuss the limitations of current risk-stratification approaches and how CyPath® Lung, a noninvasive sputum-based test, can provide objective information to help clinicians better assess the likelihood of malignancy and guide decisions about follow-up, surveillance, or biopsy.